TW200640856A - Method for preparing enantiomerically pure 4-pyrrolidinophenylbenzylether derivatives - Google Patents

Method for preparing enantiomerically pure 4-pyrrolidinophenylbenzylether derivatives

Info

Publication number
TW200640856A
TW200640856A TW095108442A TW95108442A TW200640856A TW 200640856 A TW200640856 A TW 200640856A TW 095108442 A TW095108442 A TW 095108442A TW 95108442 A TW95108442 A TW 95108442A TW 200640856 A TW200640856 A TW 200640856A
Authority
TW
Taiwan
Prior art keywords
enantiomerically pure
derivatives
pyrrolidinophenylbenzylether
preparing enantiomerically
preparing
Prior art date
Application number
TW095108442A
Other languages
English (en)
Inventor
Bruno Lohri
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of TW200640856A publication Critical patent/TW200640856A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW095108442A 2005-03-15 2006-03-13 Method for preparing enantiomerically pure 4-pyrrolidinophenylbenzylether derivatives TW200640856A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05102028 2005-03-15

Publications (1)

Publication Number Publication Date
TW200640856A true TW200640856A (en) 2006-12-01

Family

ID=36218379

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095108442A TW200640856A (en) 2005-03-15 2006-03-13 Method for preparing enantiomerically pure 4-pyrrolidinophenylbenzylether derivatives

Country Status (15)

Country Link
US (1) US7485731B2 (zh)
EP (1) EP1861362B1 (zh)
JP (1) JP4796620B2 (zh)
KR (1) KR100915736B1 (zh)
CN (1) CN101142181B (zh)
AT (1) ATE415388T1 (zh)
AU (1) AU2006224878B2 (zh)
BR (1) BRPI0608466A2 (zh)
CA (1) CA2601416C (zh)
DE (1) DE602006003879D1 (zh)
ES (1) ES2314877T3 (zh)
IL (1) IL185635A (zh)
MX (1) MX2007011154A (zh)
TW (1) TW200640856A (zh)
WO (1) WO2006097197A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016003288A8 (pt) * 2013-10-29 2020-02-04 Hoffmann La Roche processos para sintetizar n-[(3s)-1-[4-[(3-fluorofenil)metóxi]fenil]-5-oxo-pirrolidin-3-il]acetamida cristalina, e seu intermediário
CN107223052A (zh) 2015-03-27 2017-09-29 豪夫迈·罗氏有限公司 包含sembragiline的药物制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1116870C (zh) 1996-03-15 2003-08-06 萨默塞特药品有限公司 司立吉林在制备用于预防或治疗外周神经病的药物中的应用
AU1359801A (en) 1999-11-05 2001-06-06 Vela Pharmaceuticals Inc. Methods and compositions for treating reward deficiency syndrome
PA8583001A1 (es) * 2002-09-20 2004-04-23 Hoffmann La Roche Derivados de 4-pirrolidino-fenil-bencil eter como inhibidores de mao-b

Also Published As

Publication number Publication date
MX2007011154A (es) 2007-10-17
ATE415388T1 (de) 2008-12-15
AU2006224878B2 (en) 2011-02-17
KR20070103494A (ko) 2007-10-23
CA2601416C (en) 2013-07-09
US7485731B2 (en) 2009-02-03
JP2008533061A (ja) 2008-08-21
CA2601416A1 (en) 2006-09-21
WO2006097197A1 (en) 2006-09-21
EP1861362A1 (en) 2007-12-05
IL185635A (en) 2011-07-31
EP1861362B1 (en) 2008-11-26
ES2314877T3 (es) 2009-03-16
JP4796620B2 (ja) 2011-10-19
DE602006003879D1 (de) 2009-01-08
AU2006224878A1 (en) 2006-09-21
CN101142181B (zh) 2011-05-04
BRPI0608466A2 (pt) 2010-01-05
CN101142181A (zh) 2008-03-12
US20060211869A1 (en) 2006-09-21
IL185635A0 (en) 2008-01-06
KR100915736B1 (ko) 2009-09-04

Similar Documents

Publication Publication Date Title
WO2010063700A3 (en) Novel pyrazole-4 -n-alkoxycarboxamides as microbiocides
TW200722079A (en) Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
TN2010000064A1 (en) Novel herbicides
IL185545A0 (en) Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors
MX2010001364A (es) Derivados de ciclopentandiona puenteados triciclicos como herbicidas.
WO2009024342A3 (en) Novel microbiocides
UA103625C2 (en) 5-hetrocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enons as herbicides
MY161132A (en) Novel herbicides
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
UA101835C2 (uk) Спосіб отримання похідних 1-(2-галогенбіфеніл-4-іл)-циклопропанкарбонової кислоти
MX2011007932A (es) Herbicidas nuevos.
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
WO2008151828A3 (en) Novel microbiocides
WO2009127718A3 (en) Novel microbiocides
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TW200738704A (en) New process for the production of tiotropium salts
TN2010000094A1 (en) Novel herbicides
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
HK1103304A1 (en) Biotransformation of colchicinoid compounds
TW200640856A (en) Method for preparing enantiomerically pure 4-pyrrolidinophenylbenzylether derivatives
MX2009003106A (es) Nueva modificacion cristalina de 4-(n-metil-2-cloro-5-piridilmetil amino)-2,5-dihidrofuran-2-ona.
WO2009152474A3 (en) Process for the preparation of (3s)-3-amino-n-cyclopropyl-2-hydroxyalkanamide derivatives
EA200900982A1 (ru) Новый способ синтеза прамипексола и его фармацевтически приемлемых солей